Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
96 studies found for:    70806
Show Display Options
Rank Status Study
1 Recruiting Prospective, Study for the Use of Palivizumab (Synagis) in High Risk Children in Germany
Condition: Respiratory Syncytial Virus Infections
Intervention:
2 Suspended Vitamin D and Breast Cancer Biomarkers in Female Patients
Condition: Breast Cancer
Interventions: Dietary Supplement: vitamin D;   Other: placebo
3 Active, not recruiting First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
Conditions: HER2-positive Breast Cancer;   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Biological: trastuzumab;   Drug: paclitaxel;   Drug: carboplatin;   Other: placebo;   Biological: bevacizumab;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
4 Completed Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma
Condition: Uterine Carcinosarcoma
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Drug: BSI-201 (Iniparib)
5 Completed
Has Results
Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)
Condition: Gastroesophageal Reflux Disease
Intervention: Drug: Pantoprazole
6 Active, not recruiting Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
Condition: Lymphoma
Interventions: Drug: Bendamustine;   Drug: Bortezomib;   Drug: Rituximab
7 Completed S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: cyclophosphamide;   Drug: doxorubicin;   Drug: paclitaxel;   Procedure: surgery
8 Completed An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
Condition: Healthy
Intervention:
9 Completed
Has Results
Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease
Condition: Gastroesophageal Reflux Disease
Intervention: Drug: Pantoprazole
10 Completed
Has Results
Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
Conditions: Breast Cancer;   Breast Neoplasms
Interventions: Drug: Bevacizumab;   Drug: Anastrozole;   Drug: Fulvestrant
11 Completed Bipolar Study in Adults at Least 18 Years of Age
Condition: Bipolar Disorder
Intervention: Drug: lamotrigine
12 Active, not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer
Interventions: Drug: Gemcitabine Hydrochloride;   Drug: Vinorelbine Tartrate;   Drug: Cisplatin;   Drug: Docetaxel;   Drug: Pemetrexed Disodium;   Biological: Bevacizumab;   Other: Questionnaire Administration;   Other: Laboratory Biomarker Analysis
13 Unknown  Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
Condition: Breast Cancer
Intervention: Procedure: quality-of-life assessment
14 Completed
Has Results
A Study to Describe Pediatric Influenza Vaccine Coverage
Condition: Healthy
Intervention: Biological: Influenza vaccination
15 Recruiting Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions: Anemia;   Renal Insufficiency, Chronic
Interventions: Drug: Molidustat (BAY 85-3934);   Biological: Epoetin alfa/beta
16 Recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Urothelial Carcinoma;   Distal Urethral Carcinoma;   Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma;   Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;   Proximal Urethral Carcinoma;   Recurrent Bladder Carcinoma;   Recurrent Prostate Carcinoma;   Recurrent Urethra Carcinoma;   Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;   Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;   Stage IV Bladder Cancer;   Stage IV Prostate Cancer;   Stage IV Urethral Cancer;   Ureter Carcinoma
Interventions: Drug: Gemcitabine Hydrochloride;   Drug: Cisplatin;   Other: Placebo;   Biological: Bevacizumab;   Other: Laboratory Biomarker Analysis
17 Completed A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
Condition: Psoriasis
Intervention:
18 Completed Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: epoetin alfa;   Biological: filgrastim;   Drug: cisplatin;   Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
19 Completed Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific;   Weight Changes
Interventions: Drug: Megestrol Acetate;   Drug: Oxandrolone 20 mg
20 Active, not recruiting S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
Conditions: Metastatic Cancer;   Prostate Cancer
Interventions: Drug: atrasentan hydrochloride;   Drug: docetaxel;   Drug: prednisone;   Other: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years